Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study.
Elnekave E, Ben Ami E, Shamai S, Peretz I, Tamir S, Bruckheimer E, Stemmer A, Erinjeri J, Abu Quider A, Seidensticker M, Wildgruber M, Ricke J, Anazodo A, Fung KF, Zer A, Ash S. Elnekave E, et al. Among authors: peretz i. Cancers (Basel). 2022 Oct 14;14(20):5045. doi: 10.3390/cancers14205045. Cancers (Basel). 2022. PMID: 36291829 Free PMC article.
Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).
Zer A, Icht O, Yosef L, Avram D, Jacobi O, Fenig E, Kurman N, Peretz I, Shamai S, Merimsky O, Ben-Ami E, Shapira Frommer R, Schwarzbach AE, Bernstine H, Weitzen R, Vornicova O, Bar-Sela G, Stemmer SM, Lotem M. Zer A, et al. Among authors: peretz i. Ann Oncol. 2022 Jul;33(7):720-727. doi: 10.1016/j.annonc.2022.03.012. Epub 2022 Mar 23. Ann Oncol. 2022. PMID: 35339649 Free article. Clinical Trial.
Palbociclib in combination with sunitinib exerts a synergistic anti-cancer effect in patient-derived xenograft models of various human cancers types.
Moskovits N, Peretz I, Chausky E, Itzhaki E, Shmuel N, Meerson R, Tarasenko N, Kaufman A, Stemmer A, Yaffe R, Bareket-Samish A, Edison N, Goldman T, Stemmer SM. Moskovits N, et al. Among authors: peretz i. Cancer Lett. 2022 Jun 28;536:215665. doi: 10.1016/j.canlet.2022.215665. Epub 2022 Mar 28. Cancer Lett. 2022. PMID: 35358627
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.
Rotem O, Peretz I, Leviov M, Kuchuk I, Itay A, Tokar M, Paluch-Shimon S, Maimon O, Yerushalmi R, Drumea K, Evron E, Sonnenblick A, Gal-Yam E, Goldvaser H, Samih Y, Merose R, Bareket-Samish A, Soussan-Gutman L, Stemmer SM. Rotem O, et al. Among authors: peretz i. NPJ Breast Cancer. 2023 Jun 2;9(1):49. doi: 10.1038/s41523-023-00549-8. NPJ Breast Cancer. 2023. PMID: 37268607 Free PMC article.
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Brenner AJ, Peters KB, Vredenburgh J, Bokstein F, Blumenthal DT, Yust-Katz S, Peretz I, Oberman B, Freedman LS, Ellingson BM, Cloughesy TF, Sher N, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Yakov N, Mendel I, Breitbart E, Wen PY. Brenner AJ, et al. Among authors: peretz i. Neuro Oncol. 2020 May 15;22(5):694-704. doi: 10.1093/neuonc/noz231. Neuro Oncol. 2020. PMID: 31844886 Free PMC article. Clinical Trial.
246 results